Significance of infectious agents in colorectal cancer development

Journal of Cancer

Volumn 4, Issue 3, 2013, Pages 227-240

  Antonic, Vlado ^a,b,c   Stojadinovic, Alexander ^a,c,d,e,f   Kester, Kent E ^a,f,g   Weina, Peter J ^f,g   Brücher, Björn LDM ^h,i   Protic, Mladjan ^e,j,k,l   Avital, Itzhak ^f,h   Izadjoo, Mina ^a,b,c,f  

^a Combat Wound Initiative Program ^*  (United States)

^b Advancement of Military Medicine   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e United States Military Cancer Institute   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^h Bon Secours Cancer Institute   (United States)

ⁱ International Consortium of Research Excellence of the Theodor Billroth Academy   (Germany)

^j International Consortium of Research Excellence   (Germany)

^k CLINICAL CENTER OF VOJVODINA   (Serbia)

^l UNIVERSITY OF NOVI SAD   (Serbia)

more..

Author keywords

Bacteria; Cancer risk; Colon cancer; Colorectal cancer; Infection; Infectious agent; Virus

Indexed keywords

CAPSID PROTEIN; GASTRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; PROTEIN E6; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRULENCE FACTOR; VIRUS DNA;

ADENOMATOUS POLYP; AMINO ACID SEQUENCE; BACTERIAL ENDOCARDITIS; BASEMENT MEMBRANE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELLULAR STRESS RESPONSE; COLITIS; COLON FLORA; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DNA DAMAGE; DNA SEQUENCE; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HEALTH CARE; HEALTH PROMOTION; HELICOBACTER HEPATICUS; HELICOBACTER PYLORI; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INNATE IMMUNITY; INVASIVE CARCINOMA; JC VIRUS; LONG TERM SURVIVAL; MICROBIAL COMMUNITY; MICROBIOME; MILITARY SERVICE; NONHUMAN; POPULATION; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PYOGENIC LIVER ABSCESS; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING; STREPTOCOCCUS; STREPTOCOCCUS BOVIS; STREPTOCOCCUS GALLOLITICUS; UTERINE CERVIX CANCER;

EID: 84883014309     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.5835     Document Type: Review

References (98)

1. Knudson A. Alfred Knudson and his two-hit hypothesis. (Interview by Ezzie Hutchinson). Lancet Oncol. 2001;2(10):642-5.
2. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49(3):347-53.
3. Zhang B, Izadjoo M, Horkayne-Szakaly I, Morrison A, Wear DJ. Medulloblastoma and Brucellosis-Molecular Evidence of Brucella sp in Association with Central Nervous System Cancer. J Cancer. 2011;2:136-41.
4. Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, et al. Cancer incidence in the U.S. military population: comparison with rates from the SEER program. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009;18(6):1740-5.
5. [Internet] CDC. Cancer-colorectal cancer screening rates. http://www.cdc.gov/cancer/colorectal/statistics/screening_rates.htm.
6. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature reviews Microbiology. 2012;10(8):575-82.
7. Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, et al. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer research. 2001;61(6):2395-8.
8. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. The American journal of pathology. 2002;160(6):2253-7. .
9. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, et al. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer research. 2004;64(3):962-8.
10. Rudolph U, Bradley A, Birnbaumer L. Targeted inactivation of the Gi2 alpha gene with replacement and insertion vectors: analysis in a 96-well plate format. Methods in enzymology. 1994;237:366-86.
11. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 1998;94(6):703-14.
12. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002;295(5560):1726-9.
13. Engle SJ, Hoying JB, Boivin GP, Ormsby I, Gartside PS, Doetschman T. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer research. 1999;59(14):3379-86.
14. Shah SA, Simpson SJ, Brown LF, Comiskey M, de Jong YP, Allen D, et al. Development of colonic adenocarcinomas in a mouse model of ulcerative colitis. Inflammatory bowel diseases. 1998;4(3):196-202.
15. Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A. 2012;109(27):E1820-9.
16. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. The ISME journal. 2012;6(2):320-9. .
17. Roses DF, Richman H, Localio SA. Bacterial endocarditis associated with colorectal carcinoma. Annals of surgery. 1974;179(2):190-1.
18. Osawa R, Sasaki E. Novel observations of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus. Journal of clinical microbiology. 2004;42(10):4912-3.
19. Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2010;12(3):164-71.
20. Corredoira J, Alonso MP, Coira A, Casariego E, Arias C, Alonso D, et al. Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2008;27(4):285-91.
21. Corredoira J, Alonso MP, Pita J, Alonso-Mesonero D. Association between rural residency, group D streptococcal endocarditis and colon cancer? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2008;14(2):190.
22. Kok H, Jureen R, Soon CY, Tey BH. Colon cancer presenting as Streptococcus gallolyticus infective endocarditis. Singapore medical journal. 2007;48(2):e43-5.
23. Zarkin BA, Lillemoe KD, Cameron JL, Effron PN, Magnuson TH, Pitt HA. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Annals of surgery. 1990;211(6):786-91.
24. Alazmi W, Bustamante M, O'Loughlin C, Gonzalez J, Raskin JB. The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. Digestive diseases and sciences. 2006;51(4):732-6.
25. Darjee R, Gibb AP. Serological investigation into the association between Streptococcus bovis and colonic cancer. Journal of clinical pathology. 1993;46(12):1116-9.
26. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH. Association of Streptococcus bovis with carcinoma of the colon. The New England journal of medicine. 1977;297(15):800-2.
27. Dubrow R, Edberg S, Wikfors E, Callan D, Troncale F, Vender R, et al. Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology. 1991;101(3):721-5.
28. Norfleet RG, Mitchell PD. Streptococcus bovis does not selectively colonize colorectal cancer and polyps. Journal of clinical gastroenterology. 1993;17(1):25-8.
29. Burns CA, McCaughey R, Lauter CB. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. The American journal of gastroenterology. 1985;80(1):42-6.
30. Abdulamir AS, Hafidh RR, Bakar FA. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Molecular cancer. 2010;9:249.
31. Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori T, Abubaker F. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC cancer. 2009;9:403.
32. Boleij A, Roelofs R, Danne C, Bellais S, Dramsi S, Kato I, et al. Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila). 2012;5(2):260-5.
33. Corredoira-Sanchez J, Garcia-Garrote F, Rabunal R, Lopez-Roses L, Garcia-Pais MJ, Castro E, et al. Association Between Bacteremia Due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and Colorectal Neoplasia: A Case-Control Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;55(4):491-6.
34. Boleij A, Dutilh BE, Kortman G, Roelofs R, Laarakkers CM, Engelke UF, et al. Bacterial responses to a simulated colon tumor microenvironment. Molecular & cellular proteomics : MCP. 2012.
35. Boleij A, Muytjens CM, Bukhari SI, Cayet N, Glaser P, Hermans PW, et al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. The Journal of infectious diseases. 2011;203(8):1101-9.
36. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. 1994;61:1-241.
37. Di Napoli A, Petrino R, Boero M, Bellis D, Chiandussi L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. Journal of clinical pathology. 1992;45(9):796-8.
38. Ahmed N. Coevolution and adaptation of Helicobacter pylori and the case for 'functional molecular infection epidemiology'. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2011;20(6):497-503.
39. Crespo A, Suh B. Helicobacter pylori infection: epidemiology, pathophysiology, and therapy. Archives of pharmacal research. 2001;24(6):485-98.
40. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiologic reviews. 1991;13:42-59.
41. Strofilas A, Lagoudianakis EE, Seretis C, Pappas A, Koronakis N, Keramidaris D, et al. Association of helicobacter pylori infection and colon cancer. Journal of clinical medicine research. 2012;4(3):172-6.
42. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. The American journal of gastroenterology. 2001;96(12):3406-10.
43. Hartwich A, Konturek SJ, Pierzchalski P, Zuchowicz M, Labza H, Konturek PC, et al. Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer. International journal of colorectal disease. 2001;16(4):202-10.
44. Penman ID, el-Omar E, Ardill JE, McGregor JR, Galloway DJ, O'Dwyer PJ, et al. Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology. 1994;106(5):1263-70.
45. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. Journal of the National Cancer Institute. 1995;87(10):762-3.
46. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. Journal of clinical gastroenterology. 1997;25(4):605-7.
47. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000;2(1):6-9.
48. Hong SN, Lee SM, Kim JH, Lee TY, Choe WH, Lee SY, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Digestive diseases and sciences. 2012;57(8):2184-94.
49. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. American journal of epidemiology. 2012;175(5):441-50.
50. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M, Nieters A, Rothenbacher D. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer. 2007;43(8):1283-9.
51. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, et al. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2002;11(10 Pt 1):1095-9.
52. Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009;7(2):163-7.
53. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter. 2006;11(2):75-80.
54. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. International journal of colorectal disease. 2008;23(9):875-82.
55. Zhang Y, Gao C, Zhai JH. [Meta-analysis on the relationship between colorectal cancer and Helicobacter pylori infection]. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30(1):73-7.
56. Jackman RP, Schlichting C, Carr W, Dubois A. Prevalence of Helicobacter pylori in United States Navy submarine crews. Epidemiology and infection. 2006;134(3):460-4. PMCID: 2576507.
57. Taylor DN, Sanchez JL, Smoak BL, DeFraites R. Helicobacter pylori infection in Desert Storm troops. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997;25(5):979-82.
58. Furesz J, Lakatos S, Nemeth K, Fritz P, Simon L, Kacserka K. The prevalence and incidence of Helicobacter pylori infections among young recruits during service in the Hungarian Army. Helicobacter. 2004;9(1):77-80.
59. Guo Y, Cen Z, Zou Y, Fang X, Li T, Wang J, et al. Whole-genome sequence of Klebsiella pneumonia strain LCT-KP214. Journal of bacteriology. 2012;194(12):3281. PMCID: 3370881.
60. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. The American journal of gastroenterology. 2005;100(2):322-31.
61. Qu K, Liu C, Wang ZX, Tian F, Wei JC, Tai MH, et al. Pyogenic liver abscesses associated with nonmetastatic colorectal cancers: an increasing problem in Eastern Asia. World journal of gastroenterology : WJG. 2012;18(23):2948-55. PMCID: 3380322.
62. Jeong SW, Jang JY, Lee TH, Kim HG, Hong SW, Park SH, et al. Cryptogenic pyogenic liver abscess as the herald of colon cancer. Journal of gastroenterology and hepatology. 2012;27(2):248-55.
63. Huang WK, Chang JW, See LC, Tu HT, Chen JS, Liaw CC, et al. Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2012.
64. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome research. 2012;22(2):292-8. PMCID: 3266036.
65. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome research. 2012;22(2):299-306. PMCID: 3266037.
66. Saha A, Kaul R, Murakami M, Robertson ES. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer biology & therapy. 2010;10(10):961-78.
67. Bergonzini V, Salata C, Calistri A, Parolin C, Palu G. View and review on viral oncology research. Infectious agents and cancer. 2010;5:11. PMCID: 2881002.
68. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(13):7484-9. PMCID: 22112.
69. Casini B, Borgese L, Del Nonno F, Galati G, Izzo L, Caputo M, et al. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer research. 2005;25(2A):1079-85.
70. Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer research. 2002;62(23):7093-101.
71. Goel A, Li MS, Nagasaka T, Shin SK, Fuerst F, Ricciardiello L, et al. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology. 2006;130(7):1950-61.
72. Lin PY, Fung CY, Chang FP, Huang WS, Chen WC, Wang JY, et al. Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. Journal of medical virology. 2008;80(10):1828-34.
73. Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE, et al. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology. 2000;119(5):1228-35.
74. Jung WT, Li MS, Goel A, Boland CR. JC virus T-antigen expression in sporadic adenomatous polyps of the colon. Cancer. 2008;112(5):1028-36. PMCID: 2855201.
75. Hori R, Murai Y, Tsuneyama K, Abdel-Aziz HO, Nomoto K, Takahashi H, et al. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Archiv : an international journal of pathology. 2005;447(4):723-30.
76. Theodoropoulos G, Panoussopoulos D, Papaconstantinou I, Gazouli M, Perdiki M, Bramis J, et al. Assessment of JC polyoma virus in colon neoplasms. Diseases of the colon and rectum. 2005;48(1):86-91.
77. Mou X, Chen L, Liu F, Lin J, Diao P, Wang H, et al. Prevalence of JC virus in Chinese patients with colorectal cancer. PloS one. 2012;7(5):e35900. PMCID: 3350510.
78. Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. Journal of virology. 2001;75(4):1996-2001. PMCID: 115147.
79. Kado S, Kawamata Y, Shino Y, Kasai T, Kubota K, Iwasaki H, et al. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecologic oncology. 2001;81(1):47-52.
80. Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Molecular and cellular biology. 1993;13(2):775-84. PMCID: 358960.
81. Scheffner M, Munger K, Huibregtse JM, Howley PM. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. The EMBO journal. 1992;11(7):2425-31. PMCID: 556717.
82. Cheng JY, Sheu LF, Lin JC, Meng CL. Detection of human papillomavirus DNA in colorectal adenomas. Arch Surg. 1995;130(1):73-6.
83. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT. Human papillomavirus type 18 in colorectal cancer. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 2001;34(2):87-91.
84. Chen TH, Huang CC, Yeh KT, Chang SH, Chang SW, Sung WW, et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. World journal of gastroenterology : WJG. 2012;18(30):4051-8. PMCID: 3420003.
85. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2005;32 Suppl 1:S25-33.
86. Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17(11):2970-9. PMCID: 2676114.
87. Burnett-Hartman AN, Newcomb PA, Mandelson MT, Galloway DA, Madeleine MM, Wurscher MA, et al. No evidence for human papillomavirus in the etiology of colorectal polyps. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011;20(10):2288-97. PMCID: 3236024.
88. Hwang ES, Zhang Z, Cai H, Huang DY, Huong SM, Cha CY, et al. Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein. Journal of virology. 2009;83(23):12388-98. PMCID: 2786713.
89. Tomtishen JP, 3rd. Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virology journal. 2012;9:22. PMCID: 3278345.
90. Chen HP, Jiang JK, Chen CY, Chou TY, Chen YC, Chang YT, et al. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2012;54(3):240-4.
91. Akintola-Ogunremi O, Luo Q, He TC, Wang HL. Is cytomegalovirus associated with human colorectal tumorigenesis? American journal of clinical pathology. 2005;123(2):244-9.
92. Bender C, Zipeto D, Bidoia C, Costantini S, Zamo A, Menestrina F, et al. Analysis of colorectal cancers for human cytomegalovirus presence. Infectious agents and cancer. 2009;4:6. PMCID: 2674415.
93. Evans AS. Causation and disease: the Henle-Koch postulates revisited. The Yale journal of biology and medicine. 1976;49(2):175-95. PMCID: 2595276.
94. Zittleman L, Emsermann C, Dickinson M, Norman N, Winkelman K, Linn G, et al. Increasing colon cancer testing in rural Colorado: evaluation of the exposure to a community-based awareness campaign. BMC Public Health. 2009;9:288. PMCID: 2731102.
95. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-60.
96. [Internet] AmericanCancerSociety. Cancer prevention & early detection facts & figures 2008. http://www.cancer.org/research/cancerfactsfigures/cancer-prevention-early-detection-facts-figures-2008.
97. Yamane GK. Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med. 2006;77(8):789-94.
98. Hyams KC, Taylor DN, Gray GC, Knowles JB, Hawkins R, Malone JD. The risk of Helicobacter pylori infection among U.S. military personnel deployed outside the United States. The American journal of tropical medicine and hygiene. 1995;52(1):109-12